Available 1 January 2023 for: (a) non-exclusive corporate licensing by individual human health care and veterinary IVD manufacturers; (b) potential exclusive license for select health care diagnostic fields of use, or non-exclusive license with ROFN; (c) collaborative research and development agreement, with licensing conversion rights; or (d) exploratory positioning for partnering within environmental, cosmetics, and food industries.
Postings
1 January 2021
Bio-Investigations Ltd. is a specialized international healthcare venture capital firm focused on the negotiation and acquisition of exclusive worldwide licenses from leading universities, including partnering or sublicensing to major multinational pharmaceutical, chemical, and medical device companies. For over 30 years, we have been assisting new companies secure…
19 March 2018: The common thread between Gaylord Specialty Healthcare’s S.T.A.R.T. Initiative and Bio-investigations Ltd. is that both are extremely focused on technology that may play a key role in improving patient health. “S.T.A.R.T.,” Gaylord Hospital’s acronym for “Specialized Technology Assisting Rehabilitation Today,”…
11 March 2016: At Central Connecticut State University’s (CCSU) Institute of Technology and Business Development (ITBD), New Britain, CT USA, it was a beautiful Friday night venue for Innovative-Diffusion, LLC’s monthly Advisory Board meeting. Guest presentations to the Advisory Board were made by their non-profit…